Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting.

CONCLUSION: - These real-world data show that predictive low-glucose insulin suspension is more effective than pumps with stand-alone FGM for reducing hypoglycaemic events, and could be of benefit to patients at risk of hypoglycaemia as well as those lacking in hypoglycaemic awareness. PMID: 32497708 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32497708?dopt=Abstract

Source: Diabetes and Metabolism - May 31, 2020 Category: Endocrinology Authors: Telliam C, Thivolet C Tags: Diabetes Metab Source Type: research